Prognostic Value of a Prospective, Longitudinal Evaluation of Body Composition in Patients with Cirrhosis Evaluated for Liver Transplantation

进行肝移植评估的肝硬化患者身体成分的前瞻性纵向评估的预后价值

• 批准号: 399643
• 负责人: Ebadi Maryam
• 金额: $ 4.92万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-11-01 至 2021-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=399643&lang=en
• 关键词: Abnormal Body Composition Phenotypes; Competing Risk Analysis; Computed Tomography; Discriminative Mortality Model; Lipidomic; Lipodystrophy; Liver Transplant Mortality; Metabolic Pathways; Proteomic; Sarcopenia

Two main body compartments, skeletal muscle and adipose tissue (fat), exhibit independent functions. Patients with liver cirrhosis frequently experience body composition abnormalities including loss of muscle and subcutaneous fat but not visceral fat (aro

两个主要的身体区域，骨骼肌和脂肪组织（脂肪），表现出独立的功能。肝硬化患者经常出现身体成分异常，包括肌肉和皮下脂肪的减少，但没有内脏脂肪（aro）